Nanovaccines of polydopamine@tumor-associated antigens with robust prophylactic and therapeutic efficacy for cancer immunotherapy
Abstract
and distal tumor models, as well as in prophylactic murine models. This study provides a straightforward yet efficient strategy for fabricating nanovaccines with high antigen-loading capacity for tumor immunotherapy.
Fields of Study & Subjects
Immunotherapy and Immune Responses
Nanoplatforms for cancer theranostics
Cancer Immunotherapy and Biomarkers
Publication details
- Journal / source
- Nanoscale Horizons
- Volume
- 11
- Issue
- 4
- Pages
- 1145–1152
- Publication date
- 1 January 2026
- Language
- EN